AIM: To estimate radiation doses deriving from patients treated with 166Ho ferric hydroxide. METHODS: For radiation synoviorthesis about 900 100 MBq 166Ho ferric hydroxide was injected into the knee joint of 16 patients...
Keywords: 166 Ho, Radiosynoviorthese, Strahlenexposition, Strahlen-schutz
01/2003 | Nuklearmedizin, SchattauerAIM: The personnel in nuclear medicine therapy wards must be monitored according to German guidelines for incorporations of 131I...
Keywords: Inkorporationsüberwachung, Strahlenschutz, Radioiodtherapie
01/2003 | Nuklearmedizin, SchattauerAIM: The radiation synovectomy is a widespread therapeutic option in rheumatoid arthritis. However, data for the -radiation exposure are rare...
Keywords: Radiosynoviorthese, Strahlenschutz, Hautdosis, -Ortsdosimetrie
01/2003 | Nuklearmedizin, Schattauer90Y-ibritumomab tiuxetan (Zevalin) is currently approved for radioimmunotherapy of patients with relapsed or refractory follicular non-Hodgkins lymphoma pretreated with rituximab...
Keywords: Ibritumomab-Tiuxetan, Zevalin®, Yttrium-90, Radioimmuntherapie, Aktivimeter, Strahlenschutz
01/2005 | Nuklearmedizin, SchattauerAim: The number of therapies with radiopharmaceuticals labelled with 188Re is increasing requiring the documentation of the beta radiation exposure Hp(0.07) of the staff at all working and production sites and during the application and follow-up of the patient according to the new German Radiation Protection Law (StrlSchV)...
Keywords: Strahlenschutz, Hautdosis, Beta-Dosimetrie, 188Re-Therapie
01/2005 | Nuklearmedizin, SchattauerAim of this study was the assessment of the radiation exposure from preparation and application of 90Y-Zevalin, the measurement of the dose rate at the patient, the exposure of family members as well as the determination of the activity concentration in urine of patients...
Keywords: Ibritumomab Tiuxetan, Zevalin, 90Y, ß - -Strahlung, Bremsstrahlung, Radioimmuntherapie, Strahlenexposition, Hautdosis, Strahlenschutz
01/2006 | Nuklearmedizin, SchattauerRadiosynoviorthesis (RSO) with the -particle-emitting nuclide yttrium-90 is an established concept for the treatment of persistent synovitis of the knee joint...
Keywords: Yttrium-90, Radiosynoviorthese, Strahlenschutz, Chromosomenaberration, biologische Dosimetrie
01/2006 | Nuklearmedizin, Schattauer